Market Access Is it time to rethink electronic prescribing in the US? It is a fact of life that most – if not all – patients will require some form of prescription medication during their lifetime.
News Lilly inflates US facility investment spending by $4.5bn Having already committed last year to capital investments of $27 billion in the US to ward off the threat of tariffs, Eli Lilly has upped the ante.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.